Advertisement

Topics

Tesaro and OncoQuest enter trial collaboration for ovarian cancer combo therapy

14:40 EST 13 Nov 2017 | Elsevier Business Intelligence

Tesaro Inc. and OncoQuest Inc. partnered to evaluate the combination of Tesaro’s Zejula (niraparib) with OncoQuest’s oreg...

Original Article: Tesaro and OncoQuest enter trial collaboration for ovarian cancer combo therapy

NEXT ARTICLE

More From BioPortfolio on "Tesaro and OncoQuest enter trial collaboration for ovarian cancer combo therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...